NaviSurg Vision ApS
Private limited companyCVR 45639444HolteActive
NaviSurg Vision ApS is a private limited company, based in Holte, active in research and experimental development on natural sciences and engineering, founded in 2025. The company is new and has been registered for 1 years. The latest net result (2025) was a loss of DKK 453k. 6 people are registered in the company's management and ownership.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesManagement and owners, last 24 months
- New in management: Jeppe Øvli Øvlesen (chair of the board, 25/07/2025), Thomas Engelbrecht Nordkild Jonassen (board member, 25/07/2025) and Morten Asp Vonsild Lund (board member, 25/07/2025) (+3).
- Stepped down: Thomas Engelbrecht Nordkild Jonassen (ceo, 01/04/2026).
- New owners registered: M.T. Lund Holdings ApS (25/07/2025), MHAaM Holdings ApS (25/07/2025) and Quantass ApS (25/07/2025) (+5).
- No longer registered as owner: M.T. Lund Holdings ApS (24/07/2025), MHAaM Holdings ApS (24/07/2025) and Quantass ApS (24/07/2025) (+1).
Registrations, last 24 months
- 20/10/2025: Share capital changed from 64,654 DKK to 123,970 DKK
- 24/09/2025: Share capital changed from 64,047 DKK to 64,654 DKK
- 25/07/2025: Share capital changed from 20,000 DKK to 64,047 DKK
- 30/05/2025: Name changed from Perfusion Vision ApS to NaviSurg Vision ApS
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2025–2025 · amounts in DKK thousand| 2025 | Change | |
|---|---|---|
| Revenue | not stated | – |
| Gross profit | −453 | – |
| Profit before tax | −453 | – |
| Net profit | −453 | – |
| Total assets | 4,535 | – |
| Equity | 4,199 | – |
| Liabilities | 336 | – |
| Cash and cash equivalents | 4,509 | – |
| Average number of employees | 0 | – |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Annual reports
1 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 26/05/2025 – 31/12/2025 | 20/07/2026 | The company | PDF not statedXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Position in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 67,969of 69,742 Better than 3% | No. 15,844of 69,964 Better than 77% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 217of 323 Better than 33% | No. 103of 329 Better than 69% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 16,084of 16,614 Better than 3% | No. 1,477of 16,661 Better than 91% |
| All companies of type ApS66,508 companies in the comparison | No. 65,003of 66,379 Better than 2% | No. 12,695of 66,505 Better than 81% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- NaviSurg Vision ApS−DKK 453k
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- NaviSurg Vision ApS−DKK 453k
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- NaviSurg Vision ApSDKK 4.2m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- NaviSurg Vision ApS3
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- M.T. Lund Holdings ApS20%
- MHAaM Holdings ApS20%
- Quantass ApS10%
- TJ Biotech Holding ApS10%
Management
5 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Tommy Sanddal Poulsen | Director | 01/04/2026 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Jeppe Øvli Øvlesen | Chair of the board | 25/07/2025 |
| Thomas Engelbrecht Nordkild Jonassen | Board member | 25/07/2025 |
| Morten Asp Vonsild Lund | Board member | 25/07/2025 |
| Mads Aagaard Linde Madsen | Board member | 25/07/2025 |
- Founders
- M.T. Lund Holdings ApS, MHAaM Holdings ApS, Quantass ApS, TJ Biotech Holding ApS
Former management (1)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Thomas Engelbrecht Nordkild Jonassen | CEO | 26/05/2025 | 01/04/2026 |
Signing rule: Selskabet tegnes af den samlede bestyrelse, af bestyrelsens formand i forening med et bestyrelsesmedlem eller af et bestyrelsesmedlem i forening med en direktør.
Address and production units
1 active production unitsDronninggårds Alle 134
2840 Holte
| Production unit | Address | Employees | P number |
|---|---|---|---|
| NaviSurg Vision ApS | Dronninggårds Alle 134, 2840 Holte | 3 | 1031369750 |
Purpose
Selskabets formål er at drive virksomhed i ind- og udland inden for udvikling, markedsføring og kommercialisering af medicinsk udstyr, herunder ved gennemførelse af forsknings- og udviklingsaktiviteter, og andre hermed relaterede aktiviteter.
The purpose is quoted from the register in Danish.
Changes year by year
25 registered events20263 changesaccounts 1 · management 2
- AccountsAnnual report for 2025 published
- ManagementTommy Sanddal Poulsen appointed director
- ManagementThomas Engelbrecht Nordkild Jonassen stepped down as ceo
202522 changescapital 3 · management 5 · ownership 12 · name 1 · founded 1
- CapitalShare capital changed from 64,654 DKK to 123,970 DKK
- CapitalShare capital changed from 64,047 DKK to 64,654 DKK
- CapitalShare capital changed from 20,000 DKK to 64,047 DKK
- ManagementJeppe Øvli Øvlesen appointed chair of the board
- ManagementThomas Engelbrecht Nordkild Jonassen appointed board member
- ManagementMorten Asp Vonsild Lund appointed board member
- ManagementMads Aagaard Linde Madsen appointed board member
- OwnershipTJ Biotech Holding ApS registered as owner (10%)
- OwnershipM.T. Lund Holdings ApS registered as owner (20%)
- OwnershipMHAaM Holdings ApS registered as owner (20%)
- OwnershipQuantass ApS registered as owner (10%)
- OwnershipM.T. Lund Holdings ApS is no longer registered as owner
- OwnershipMHAaM Holdings ApS is no longer registered as owner
- OwnershipQuantass ApS is no longer registered as owner
- OwnershipTJ Biotech Holding ApS is no longer registered as owner
- NameName changed from Perfusion Vision ApS to NaviSurg Vision ApS
- FoundedRegistered as Perfusion Vision ApS
- ManagementThomas Engelbrecht Nordkild Jonassen appointed ceo
- OwnershipM.T. Lund Holdings ApS registered as owner (25%)
- OwnershipMHAaM Holdings ApS registered as owner (25%)
- OwnershipQuantass ApS registered as owner (25%)
- OwnershipTJ Biotech Holding ApS registered as owner (25%)
Related companies
Same industry in Rudersdal
- Dhi A/S345 employees
- Bioneer A/S82 employees
- Dansk Fundamental Metrologi A/S55 employees
- Glycom A/S51 employees
- Evaxion A/S46 employees
- Presto Engineering Denmark ApS39 employees
Same people in management
- Chemometec A/Svia Jeppe Øvli Øvlesen
- Qiagen Aarhus A/Svia Jeppe Øvli Øvlesen
- Cercare Medical A/Svia Jeppe Øvli Øvlesen
- Hybridgenerator Apsvia Jeppe Øvli Øvlesen
- Mindway AI ApSvia Jeppe Øvli Øvlesen
- Getinge Cetrea A/Svia Jeppe Øvli Øvlesen
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.